TY - JOUR A2 - 阿加瓦尔，阿尼尔K. AU - 纳扎勒，查希尔A. AU - Khazneh，伊马德N. AU - 拉比，拉赞A. AU - Hammoudeh，Ahlam酒店A. AU - 加尼姆，艾哈迈德F. AU - 子丹，穆罕默德A. PY - 2020 DA - 2020年5月13日TI - 透析患者的甲状腺功能减退症患病率在巴勒斯坦：一个横断面研究SP - 2683123 VL - 2020 AB - 介绍。肾脏会影响甲状腺在其功能引起各种紊乱每当肾脏受损，甚至在其作业的小瑕疵，这使得透析患者更容易出现甲状腺疾病与死亡率和发病率随后增加。这项研究旨在评估透析患者及其相关因素甲状腺疾病（低血糖和甲亢）的患病率。 方法。本横断面研究是在安纳贾赫国立大学医院的透析单元进行。209 dialysis patients (60% were male, 57.6 ± 14.5 years, mean age) meeting our inclusion criteria were tested for thyrotropin (TSH) and free thyroxine (FT4) in addition to routine laboratory tests. 发现。The prevalence of hypothyroidism was assessed as 16.3% (95% CI = 11.29% to 21.3%), overt hypothyroidism was 9.1%, and subclinical hypothyroidism was 7.2%. Subclinical hyperthyroidism prevalence was 1%, and no overt hyperthyroidism cases were reported. We observed no significant association between thyroid state and age, gender, duration of dialysis, or weight. 讨论。甲状腺功能减退症（亚临床都和公开型）常见于透析患者，其症状是普通甚至在甲状腺功能正常透析患者抱怨，这保证筛查项目多的研究对甲状腺激素补充剂的功效。SN - 2090-214X UR - https://doi.org/10.1155/2020/2683123 DO - 10.1155 /二百六十八万三千一百二十三分之二千○二十零JF - 国际肾脏病杂志PB的 - Hindawi出版KW - ER -